InvestorsHub Logo
Followers 148
Posts 7877
Boards Moderated 2
Alias Born 03/15/2002

Re: peregr post# 283813

Tuesday, 01/17/2017 11:33:36 AM

Tuesday, January 17, 2017 11:33:36 AM

Post# of 345787

Only investment I own where I have no idea what the strategy is anymore.

Really? Not very complicated.

1. The company is putting its resources in Avid to become profitable within a short time frame - some time within the next fiscal year.
2. It is creating a test kit which involves low cost but huge profit potential. The time frame to market coincides with Avid's time frame - product to market within the next fiscal year.

Avid has shown a verifiable track record of success and is on course to become profitable within the next two quarters and unless something occurs way out of left field, they will most likely be profitable every quarter of the next fiscal year.

The Exosome project enters a multi-billion dollar business model that has the potential of making PPHM a stand alone company financially capable of bringing its own products to market. I think if people researched this one aspect only, they would find a reason to invest heavily in PPHM.

While the above are being accomplished, they paid a middleman to find three different companies that will take over testing of their main product. By doing so, they have virtually eliminated the high cost of bringing a drug to market, but in return have lost most of the control over their drug testing.

For a company this size, their strategy is innovative and well thought out. The foundation is finally strong.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News